EX-16 3 a03-3503_1ex16.htm EX-16

EXHIBIT 16

 

September 19, 2003

 

 

Securities and Exchange Commission

Division of Corporation Finance

450 Fifth Street, N.W.

Washington, DC  20549

 

Re:                               Lee Pharmaceuticals

SEC File No. 1-7335

 

Gentlemen:

 

We have read Item 4 of the Form 8-K of Lee Pharmaceuticals dated September 18, 2003 and agree with the statements concerning our Firm contained therein.

 

Very truly yours,

 

 

/s/ Caldwell, Becker, Dervin, Petrick & Co., L.L.P.

 

 

CALDWELL, BECKER, DERVIN, PETRICK & CO., L.L.P.